Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-2994
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review ; volume:5 ; number:1 ; day:14 ; month:11 ; year:2016 ; pages:1-11 ; date:12.2016
Antimicrobial resistance and infection control ; 5, Heft 1 (14.11.2016), 1-11, 12.2016
- Creator
-
Pássaro, Leonor
- Contributor
-
Harbarth, Stephan
Landelle, Caroline
SpringerLink (Online service)
- DOI
-
10.1186/s13756-016-0150-3
- URN
-
urn:nbn:de:1111-201612071062
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pássaro, Leonor
- Harbarth, Stephan
- Landelle, Caroline
- SpringerLink (Online service)
Other Objects (12)
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Predicting hospital-acquired pneumonia among schizophrenic patients: a machine learning approach
Definitions of hospital-acquired pneumonia in trauma research: a systematic review
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumonia
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Predicting hospital-acquired pneumonia among schizophrenic patients: a machine learning approach
Definitions of hospital-acquired pneumonia in trauma research: a systematic review
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumonia
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Predicting hospital-acquired pneumonia among schizophrenic patients: a machine learning approach
Definitions of hospital-acquired pneumonia in trauma research: a systematic review
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumonia
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients